Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

MEDNAX Inc Issues Q1 2013 EPS Guidance Below Analysts' Estimates; Comments On Q1 2013 Total Same-Unit Revenue Growth Guidance


Thursday, 31 Jan 2013 06:00am EST 

MEDNAX Inc announced that for the first quarter of 2013, it expects earnings will be in a range of $1.05 to $1.10 per share. This outlook assumes that total same-unit revenue growth will grow by 1.0% to 3.0% from the prior-year period. This same-unit growth forecast is expected to be divided evenly between patient volume, assuming growth across all MEDNAX physician specialties and net reimbursement growth, including improvements from commercial payor contracts, offset by variability in the mix of services reimbursed under government payor programs. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $1.15 for the first quarter of 2013. 

Company Quote

64.7
0.8 +1.25%
26 Nov 2014